Impact of Personalized and Remote Support Centered on Exercise and Physical Activity for Breast Cancer Patients
eMOUVOIR
Randomized Study Estimating the Impact of a Personalized and Remote Support Centered on Exercise and Physical Activity for Patients After Breast Cancer
3 other identifiers
interventional
824
1 country
22
Brief Summary
A study that evaluates the benefits of a personalized remote exercise and physical activity coaching compared with the standard supportive approach in terms of health-related quality of life at 12 months in breast cancer survivors treated in an adjuvant setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2020
Longer than P75 for not_applicable
22 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2019
CompletedFirst Posted
Study publicly available on registry
September 2, 2020
CompletedStudy Start
First participant enrolled
December 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2024
CompletedMarch 18, 2026
September 1, 2025
3.5 years
June 5, 2019
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Quality of Life (QoL): SF 36 PCS
This study will evaluate, in each randomized group, the difference between the baseline score and the 12-month score of summary score of this questionnaire: PCS (Physical Component Summary)
1 year from the inclusion
Quality of Life (QoL): SF 36 MCS
This study will evaluate, in each randomized group, the difference between the baseline score and the 12-month score of summary score of this questionnaire: MCS (Mental Component Summary)
1 year from the inclusion
Secondary Outcomes (14)
Success/Failure score
at 12 months after start of the program
Health Related Quality of Life (HRQoL)
at the baseline, 4 months, 8 months and 12 months.
Practice of Exercise and Physical Activities (EPA)
at the baseline, 4 months, 8 months and 12 months.
Fatigue
at the baseline, and 12 months.
Pain level
at the baseline, and 12 months.
- +9 more secondary outcomes
Study Arms (2)
Arm A: personalized coaching for physical activities
EXPERIMENTALThis arm consists of providing patients with a personalized coaching focused on exercise and physical activity, with or without connected watch.
Arm B: standard supportive approach
ACTIVE COMPARATORThe standard supportive approach will consist in recommendations made during visits with the oncologist. The delivery of post-treatment care by oncologists and their team systematically provide exercise advice patients including recommendations for strength training and aerobic activity.
Interventions
Patients will receive personalized physical activity coaching with an online digital platform to take online educational workshops and interact with other peers of the cohort with a online private forum. They will also have a connected watch that will measure several physical activity metrics.
Patients will receive the standard recommendations during their visits with the oncologist. The exercise recommendations include strength training and aerobic activities.
Eligibility Criteria
You may qualify if:
- Patient ≥18;
- Diagnosis of invasive non-metastatic breast cancer;
- months (+/- 3 months) after the end of the treatment by surgery and/or radiotherapy and/or chemotherapy and/or other "short-term" systemic treatment : immunotherapy, PARP inhibitor, trastuzumab or TDM1 ; the continuation of hormonotherapy (more or less associated with an anti-CDK4/6), trastuzumab or TDM1 is possible during the study period;
- SF-36 filled in completely
- Medical certificate for sports practice delivered by a healthcare professional or oncologist. Neither the previous sports practice, nor the motivation for the proposed program is necessary to participate in the program.
- Agreement for follow-ups during the study period lasting 12 months;
- Ability to understand, read and write French;
- Patient covered by the French "Social Security" regime;
- Signed informed consent for the participation in the study, including the randomization with a 50%/50% chance of being allocated to one or the other group.
You may not qualify if:
- Relapse of invasive breast cancer (loco-regional relapse, contralateral relapse)
- Inability to exercise because of a severe handicap or vulnerability. These contraindications are left to the discretion of the healthcare professional assessing capacity (ex : severe malnutrition, pregnancy …);
- Metastatic cancer;
- Expressed preference for one arm;
- Inability to comply with follow-up (4 and 12 months) of the trial (geographical, social, medical or psychological reasons);
- Person under guardianship or curatorship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Oscar Lambretlead
- Stimulabcollaborator
Study Sites (22)
Centre Léon Bérard
Lyon, Auvergne-Rhône-Alpes, 69379, France
Groupe Hospitalier Bretagne Sud
Lorient, Brittany Region, 56100, France
CARIO Hôpital Privé des Côtes d'Armor
Plérin, Brittany Region, 22190, France
Centre Eugène marquis
Rennes, Brittany Region, 35042, France
Centre d'oncologie et radiothérapie Saint-Jean
Saint-Doulchard, Centre-Val de Loire, 18230, France
Sainte Catherine Institut du Cancer Avignon Provence
Avignon, France, 84918, France
Centre Marie Curie
Arras, Hauts-de-France, 62000, France
Centre Pierre Curie
Beuvry, Hauts-de-France, 62660, France
CH de Boulogne-sur-Mer
Boulogne-sur-Mer, Hauts-de-France, 62321, France
Centre de radiothérapie Amethyst
Compiègne, Hauts-de-France, 60200, France
Institut André Dutreix
Dunkirk, Hauts-de-France, 59240, France
Centre Oscar Lambret
Lille, Hauts-de-France, 59020, France
Centre Gray-Amethyst Radiothérapie
Maubeuge, Hauts-de-France, 59600, France
CH de Roubaix
Roubaix, Hauts-de-France, 59056, France
Centre Joliot Curie
Saint-Martin-Boulogne, Hauts-de-France, 62280, France
Centre de cancérologie Les Dentellières
Valenciennes, Hauts-de-France, 59300, France
CH de Valenciennes
Valenciennes, Hauts-de-France, 59322, France
Centre Hospitalier Eure-Seine - Hôpital d'Evreux
Évreux, Normandy, 27015, France
Institut Bergonié
Bordeaux, Nouvelle-Aquitaine, 33076, France
Polyclinique Bordeaux Nord Aquitaine
Bordeaux, Nouvelle-Aquitaine, 33077, France
Hôpital Privé du Confluent
Nantes, Pays de la Loire Region, 44277, France
Institut Gustave Roussy
Villejuif, Île-de-France Region, 94800, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurence VANLEMMENS, MD
Centre Oscar Lambret
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2019
First Posted
September 2, 2020
Study Start
December 18, 2020
Primary Completion
June 26, 2024
Study Completion
June 26, 2024
Last Updated
March 18, 2026
Record last verified: 2025-09